FGFR3 mutations are one of the most prevalent somatic mutations in UC; thus, FGFR3 may serve as a biomarker for patient selection, disease diagnosis and prognosis monitoring.

Mutations of FGFR3, FGFR3– TACC3 and FGFR3– BAIAP2L1 fusion proteins are frequently associated with bladder cancer, while some FGFR3 mutations are also associated with a better prognosis.

Several versions (isoforms) of the FGFR3 protein are produced from the FGFR3 gene. The different isoforms are found in various tissues of the body, and they interact with a variety of growth factors.

Dec 20, 2023 · Mutations in the Fgfr3 gene can disrupt the normal function of the fibroblast growth factor receptor 3 protein. This can result in abnormal cell growth and division, leading to the development of …

Jul 1, 2025 · We analyzed a protein called fibroblast growth factor receptor 3 (FGFR3) in patients with cancer of the urinary tract. We found that more aggressive tumors had fewer genetic changes in …

A new skeletal dysplasia with severe tibial bowing, profound developmental delay and acanthosis nigricans is caused by a Lys 650 Met mutation in fibroblast growth factor receptor 3 (FGFR3).

Dec 30, 2024 · Here, the authors develop a deep-learning model to detect FGFR3 mutations in MIBC/mUC from routine histopathology slides, allowing for highly sensitive, rapid, and cost-effective …

FGFR3 gene rearrangements are typical alterations in bladder cancer (Nelson et al., 2016; Parker et al., 2014). In this review, we summarize the most relevant evidence on the role of FGFR3 and the state …

Apr 12, 2023 · FGFR2 alterations are rare in this disease; FGFR3 mutations are more common. To date, there are no data indicating whether mutations or fusions are more associated with benefit.

In this review, we revisit the pivotal role of fibroblast growth factor receptor 3 (FGFR3) in bladder cancer (BLCA), underscoring its prevalence in both non-muscle-invasive and muscle-invasive forms of the …